Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4138

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Atorvastatin Calcium 10 mg film-coated tablets, quantity 90 tablets. The label includes the proprietary and generic name, dosage form, and strength. It shows the NDC 70518-4138-00 and states the manufacturer as Ascend Labs, LLC, Montvale, NJ. It also notes repackaging by RemedyRepack Inc., Indiana, PA, and provides storage instructions and a warning to keep medication out of reach of children.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph showing cumulative incidence (%) over time (years) comparing atorvastatin with placebo. The graph has two lines: a solid line representing atorvastatin and a dashed line representing placebo. The x-axis ranges from 0 to 3.5 years and the y-axis from 0.0 to 4.0% cumulative incidence. Atorvastatin shows a lower cumulative incidence than placebo over time.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Kaplan-Meier cumulative hazard curve showing the time to first primary endpoint over four years of follow-up, comparing Atorvastatin (solid line) and placebo (dashed line). The vertical axis shows cumulative hazard percentage, and the horizontal axis shows years. The graph includes a hazard ratio (HR) of 0.63 with confidence interval and a p-value of 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph comparing Atorvastatin 10 mg and 80 mg over five years, showing the percentage of subjects experiencing a major cardiovascular event. The X-axis represents time to first major cardiovascular endpoint in years, and the Y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio and p-value.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of atorvastatin calcium, shown as a complex molecule with multiple rings, hydroxyl groups, and a calcium ion complexation. The diagram includes molecular connectivity and indicates associated calcium ions and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.